318 related articles for article (PubMed ID: 9849488)
1. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).
Duffy CP; Elliott CJ; O'Connor RA; Heenan MM; Coyle S; Cleary IM; Kavanagh K; Verhaegen S; O'Loughlin CM; NicAmhlaoibh R; Clynes M
Eur J Cancer; 1998 Jul; 34(8):1250-9. PubMed ID: 9849488
[TBL] [Abstract][Full Text] [Related]
2. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells.
Paul S; Breuninger LM; Kruh GD
Biochemistry; 1996 Nov; 35(44):14003-11. PubMed ID: 8909298
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells.
Kobayashi S; Okada S; Yoshida H; Fujimura S
Tohoku J Exp Med; 1997 Mar; 181(3):361-70. PubMed ID: 9163851
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.
Loe DW; Almquist KC; Deeley RG; Cole SP
J Biol Chem; 1996 Apr; 271(16):9675-82. PubMed ID: 8621643
[TBL] [Abstract][Full Text] [Related]
6. Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.
Liang Y; O'Driscoll L; McDonnell S; Doolan P; Oglesby I; Duffy K; O'Connor R; Clynes M
Int J Cancer; 2004 Sep; 111(4):484-93. PubMed ID: 15239124
[TBL] [Abstract][Full Text] [Related]
7. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
11. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
12. Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells.
Chauvier D; Morjani H; Manfait M
Breast Cancer Res Treat; 2002 May; 73(2):113-25. PubMed ID: 12088114
[TBL] [Abstract][Full Text] [Related]
13. Unusual anti-leukemia activity of nanoformulated naproxen and other non-steroidal anti-inflammatory drugs.
Kumar R; Siril PF; Javid F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1335-44. PubMed ID: 27612834
[TBL] [Abstract][Full Text] [Related]
14. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
18. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
[TBL] [Abstract][Full Text] [Related]
20. Selective potentiation of drug cytotoxicity by NSAID in human glioma cells: the role of COX-1 and MRP.
Roller A; Bähr OR; Streffer J; Winter S; Heneka M; Deininger M; Meyermann R; Naumann U; Gulbins E; Weller M
Biochem Biophys Res Commun; 1999 Jun; 259(3):600-5. PubMed ID: 10364464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
